IN2014DN09817A - - Google Patents

Info

Publication number
IN2014DN09817A
IN2014DN09817A IN9817DEN2014A IN2014DN09817A IN 2014DN09817 A IN2014DN09817 A IN 2014DN09817A IN 9817DEN2014 A IN9817DEN2014 A IN 9817DEN2014A IN 2014DN09817 A IN2014DN09817 A IN 2014DN09817A
Authority
IN
India
Prior art keywords
active
formulation
skin
patient
occlusivity
Prior art date
Application number
Other languages
English (en)
Inventor
Hyder Aliyar
Robert O Huber
Gary L Loubert
Gerald K Schalau
Original Assignee
Dow Corning
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning filed Critical Dow Corning
Publication of IN2014DN09817A publication Critical patent/IN2014DN09817A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN9817DEN2014 2012-04-27 2014-11-19 IN2014DN09817A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261639611P 2012-04-27 2012-04-27
PCT/US2013/030212 WO2013162723A1 (en) 2012-04-27 2013-03-11 Topical formulation compositions containing silicone based excipients to deliver actives to a substrate

Publications (1)

Publication Number Publication Date
IN2014DN09817A true IN2014DN09817A (zh) 2015-07-31

Family

ID=48045040

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9817DEN2014 IN2014DN09817A (zh) 2012-04-27 2014-11-19

Country Status (6)

Country Link
US (1) US20150141389A1 (zh)
EP (1) EP2841106A1 (zh)
JP (1) JP6093007B2 (zh)
CN (1) CN104271160B (zh)
IN (1) IN2014DN09817A (zh)
WO (1) WO2013162723A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012228B (zh) * 2015-08-17 2018-04-20 郑州和济生物科技股份有限公司 防止疤痕形成及早期修复的玻尿酸硅凝胶组合物及制备方法
GB201616223D0 (en) * 2016-09-23 2016-11-09 University College Cardiff Consultants Limited Topical treatment patch
JP2020508993A (ja) * 2017-02-15 2020-03-26 ボタニクス ファーマシューティカルズ リミテッド ざ瘡を処置するための組成物
US11452701B2 (en) 2017-12-04 2022-09-27 Johnson & Johnson Consumer Inc. Topical emulsion composition containing nonsteroidal anti-inflammatory drug
US20190224137A1 (en) * 2018-01-24 2019-07-25 Botanix Pharmaceuticals Ltd. Cannabinoid Dosing Regime for Acne
JP2021512067A (ja) * 2018-01-24 2021-05-13 ボタニクス ファーマシューティカルズ リミテッド ざ瘡のためのカンナビノイド投薬レジメン
AT521126A2 (de) * 2018-03-29 2019-10-15 Bcsk Biocid Gmbh Sprühpflasterzusammensetzung
WO2019213142A1 (en) * 2018-04-30 2019-11-07 Eleblend Llc Cosmetic compositions
US11304416B2 (en) * 2018-09-24 2022-04-19 Relevo Labs, Llc Cyclopentasiloxane and cationic biocide as a formulation additive to enhance persistent sanitizing and miscibility
CA3138194A1 (en) 2019-04-30 2020-11-05 Bayer Healthcare Llc Topical analgesic gel compositions
TWI691343B (zh) * 2019-05-02 2020-04-21 邵明遠 液體繃帶組成物之用途
WO2021061913A1 (en) * 2019-09-27 2021-04-01 Encube Ethicals, Pvt. Ltd. Diclofenac sodium topical solution
CN117750951A (zh) * 2021-07-29 2024-03-22 3M创新有限公司 包含水杨酸的成膜组合物和使用方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000063267A (ja) * 1998-08-21 2000-02-29 Senju Pharmaceut Co Ltd 経皮吸収貼付剤
FR2867682B1 (fr) * 2004-03-22 2009-06-05 Galderma Res & Dev Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
WO2005123092A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
GB0506141D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A topical compostion and its uses
US20070207107A1 (en) * 2006-03-03 2007-09-06 Gareth Winckle Silicone based emulsions for topical drug delivery
EP3284470A1 (en) * 2006-11-15 2018-02-21 Arthritis Relief Plus Ltd. Topical formulation comprising comfrey extract
US20100184714A1 (en) * 2007-07-11 2010-07-22 Victor Albert Raul Compositions For Delivering A Drug
US20100092408A1 (en) * 2008-10-14 2010-04-15 Laurie Ellen Breyfogle Resilient personal care composition comprising polyalkyl ether containing siloxane elastomers
US20100099766A1 (en) * 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
WO2011006100A1 (en) * 2009-07-09 2011-01-13 Crescendo Therapeutics, Llc Method of wound healing and scar modulation
WO2011113000A1 (en) * 2010-03-11 2011-09-15 Chemsmart, Llc Novel ester containing compositions and methods

Also Published As

Publication number Publication date
CN104271160A (zh) 2015-01-07
US20150141389A1 (en) 2015-05-21
JP6093007B2 (ja) 2017-03-08
CN104271160B (zh) 2017-08-08
EP2841106A1 (en) 2015-03-04
JP2015514801A (ja) 2015-05-21
WO2013162723A1 (en) 2013-10-31

Similar Documents

Publication Publication Date Title
IN2014DN09817A (zh)
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
BR112016014830A2 (pt) Conjugados de fármaco de anticorpo (adcs) com inibidores de ksp
BR112013008601A8 (pt) Formulações de emulsão de clevidipina contendo agentes antimicrobianos
MX2011013150A (es) Composicion farmaceutica para uso en oftalmologia medica y veterinaria.
MX352824B (es) Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado común e inflamación.
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
MX2013013809A (es) Dispositivos expandibles con revestimiento de una composicion de paclitaxel.
MX2016008138A (es) Sistema para el suministro transdermico de ingredientes activos.
MX2015002239A (es) Formulacion oftalmica de lipido polioxilo o de acido graso polioxilo y tratamiento de padecimientos oculares.
NZ703574A (en) A topical composition comprising a film-forming polymer for delivering an active ingredient to skin
MX2012002727A (es) Sistema terapeutico transdermico para administrar fentanilo o un analogo del mismo.
MY163809A (en) Transdermal drug delivery system containing donepezil
EP3300734A3 (en) Use of levocetirizine and montelukast in the treatment of autoimmune disorders
IL233693A (en) A system for the translocation of a drug and its use in the treatment of mitochondrial diseases
BR112015011778A2 (pt) métodos para administrar e avaliar drogas de expulsão de nitrogênio para o tratamento de encefalopatia hepática
EA201391689A1 (ru) Система доставки лекарственного средства
WO2014164285A3 (en) Use of levocetirizine and montelukast in the treatment of vasculitis
BRPI0607172A2 (pt) método para a ministração de pelo menos uma substáncia farmaceuticamente ativa a um paciente, combinação de medicamentos e uso de pelo menos uma substáncia farmaceuticamente ativa para a fabricação de uma combinação de medicamentos
DK2802319T3 (da) Fastdosiskombinationsterapi for parkinsons sygdom
MX2013013808A (es) Dispositivos expandibles con revestimiento de una composicion de rapamicina.
MX2015016418A (es) Dihidroetorfina para proporcionar el alivio del dolor y la anestesia.
MX2015007731A (es) Formulacion farmaceutica que comprende ciclesonida.
BR102012028120B8 (pt) Uso de um ou mais derivados de ingenol, composição farmacêutica e medicamento
PH12015501538A1 (en) Topical ocular analgesic agents